During the past decade, Tel Aviv Sourasky Medical Center Department of Hematology conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 10 clinical trials were completed, i.e. on average, 142.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tel Aviv Sourasky Medical Center Department of Hematology" #1 collaborator was "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator and "Assign Data Management and Biostatistics GmbH" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Tel Aviv Sourasky Medical Center Department of Hematology" are "Multiple Myeloma" (3 trials), "B-Cell Chronic Lymphocytic Leukemia" (1 trials), "B-cell Chronic Lymphocytic Leukemia" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials) and "Crohn Disease" (1 trials). Many other conditions were trialed in "Tel Aviv Sourasky Medical Center Department of Hematology" in a lesser frequency.

Most popular intervention types in "Tel Aviv Sourasky Medical Center Department of Hematology" are "Drug" (15 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Chlorambucil" (2 trials), "Cyclophosphamide" (2 trials), "Fludarabine" (2 trials) and "GED-0301" (2 trials). Other intervention names were less common.

The vast majority of trials in "Tel Aviv Sourasky Medical Center Department of Hematology" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Tel Aviv Sourasky Medical Center Department of Hematology". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Tel Aviv Sourasky Medical Center Department of Hematology, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Tel Aviv Sourasky Medical Center Department of Hematology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".